• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  Botulinum toxin type A
Trade Name:  Botox
Date Designated:  03/22/1984
Orphan Designation:  Treatment of strabismus and blepharospasms
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  12/29/1989 
Approved Labeled Indication:  Treatment of strabismus associated with dystonia in adults (patients 12 years of age and above)
Exclusivity End Date:    12/29/1996 
Exclusivity Protected Indication* :  
Allergan, Inc.
2525 Dupont Drive
P.O. Box 19534
Irvine, California 92713
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
 
Generic Name:  Botulinum toxin type A
Trade Name:  Botox
Date Designated:  03/22/1984
Orphan Designation:  Treatment of strabismus and blepharospasms
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  12/30/1989 
Approved Labeled Indication:  Treatment of blepharospasm associated with dystonia in adults (patients 12 years of age and above)
Exclusivity End Date:    12/30/1996 
Exclusivity Protected Indication* :  
Allergan, Inc.
2525 Dupont Drive
P.O. Box 19534
Irvine, California 92713
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-